- Home
- CRVS vs NGS Comparison
CRVS vs NGS Comparison
Compare CRVS & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- NGS
- Stock Information
- Founded
- CRVS 2014
- NGS 1998
- Country
- CRVS United States
- NGS United States
- Employees
- CRVS N/A
- NGS N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- CRVS Health Care
- NGS Energy
- Exchange
- CRVS Nasdaq
- NGS Nasdaq
- Market Cap
- CRVS 305.4M
- NGS 305.2M
- IPO Year
- CRVS 2016
- NGS 2002
- Fundamental
- Price
- CRVS $5.75
- NGS $26.20
- Analyst Decision
- CRVS Strong Buy
- NGS Strong Buy
- Analyst Count
- CRVS 4
- NGS 2
- Target Price
- CRVS $15.00
- NGS $32.50
- AVG Volume (30 Days)
- CRVS 518.7K
- NGS 58.3K
- Earning Date
- CRVS 08-07-2025
- NGS 08-11-2025
- Dividend Yield
- CRVS N/A
- NGS 1.53%
- EPS Growth
- CRVS N/A
- NGS 33.85
- EPS
- CRVS N/A
- NGS 1.42
- Revenue
- CRVS N/A
- NGS $164,109,000.00
- Revenue This Year
- CRVS N/A
- NGS $9.75
- Revenue Next Year
- CRVS N/A
- NGS $14.27
- P/E Ratio
- CRVS N/A
- NGS $18.41
- Revenue Growth
- CRVS N/A
- NGS 14.77
- 52 Week Low
- CRVS $2.54
- NGS $16.73
- 52 Week High
- CRVS $10.00
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- NGS 57.40
- Support Level
- CRVS $5.28
- NGS $25.05
- Resistance Level
- CRVS $5.64
- NGS $26.54
- Average True Range (ATR)
- CRVS 0.30
- NGS 1.08
- MACD
- CRVS 0.03
- NGS 0.13
- Stochastic Oscillator
- CRVS 77.70
- NGS 81.67
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.